An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer

Name: An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
License: Public Domain

Eisai Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

differentiated thyroid cancer, thyroid cancer, radioiodine-refractory, differentiated, expanded access

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 805915
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.